Mirjam W. Huizenga
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Acetaminophen alters endogenous lipid signaling and attenuates pathological pain through a mechanism requiring diacylglycerol lipase, monoacylglycerol lipase and cannabinoid CB1 receptors in mice.
Journal: Neuropharmacology
Published: June 03, 2026
Spatially Resolved Mapping of Monoacylglycerol Lipase Activity in the Brain.
Journal: ACS chemical neuroscience
Published: November 28, 2025
Spatially resolved mapping of monoacylglycerol lipase activity in the brain.
Journal: bioRxiv : the preprint server for biology
Published: July 17, 2025
Acetaminophen attenuates pathological pain through a mechanism that requires CB1 cannabinoid receptors and the enzyme diacylglycerol lipase in mice.
Journal: bioRxiv : the preprint server for biology
Published: June 04, 2025
A Highly Selective and Versatile Probe Platform for Visualization of Monoacylglycerol Lipase.
Journal: Angewandte Chemie (International ed. in English)
Published: July 16, 2024
Structure-Activity Relationship Studies of Aryl Sulfoxides as Reversible Monoacylglycerol Lipase Inhibitors.
Journal: Journal of medicinal chemistry
Published: July 11, 2024
Generate what you can make: achieving in-house synthesizability with readily available resources in de novo drug design.
Journal: Journal of cheminformatics
Published: February 28, 2024
A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence.
Journal: Nature communications
Published: December 20, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026